Effects of diet on blood lipids and metabolism
Official title: Investigating Blood Lipid Responses to Dietary Macronutrient Content
Run by University of Oxford · NCT05973539 · Data updated 2026-11-12
This study is testing whether a low carbohydrate, high-fat diet or a high carbohydrate, low-fat diet can better improve blood fat levels and liver health in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 2 sites (Oxford and 1 other locations) |
| Status | Recruiting |
| Started | February 15, 2023 |
| Main results expected | January 2028 |
| Study ends | January 2028 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT05973539 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 with a BMI between 19 and 35 who are free from metabolic diseases.
✕Probably not a fit
Patients with metabolic conditions or those currently on weight loss diets may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how different macronutrient compositions in diets, specifically high carbohydrate versus high fat, affect blood lipid responses and liver metabolism in adults without metabolic diseases. Participants will be randomly assigned to consume either a low carbohydrate, high-fat diet or a high carbohydrate, low-fat diet for up to 28 days while maintaining stable body weight. The study also aims to explore the interaction between dietary macronutrient content and individual genetic factors on metabolic responses. By analyzing plasma triglyceride concentrations and liver fat content, the research seeks to clarify optimal dietary approaches for reducing the risk of cardiometabolic diseases.
Why it matters
Potential benefit: If successful, this study could provide personalized dietary recommendations to lower the risk of cardiometabolic diseases.
How similar studies have gone: Other studies have explored dietary impacts on metabolic health, but this specific approach examining genetic interactions is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged ≥18 to ≤65 years * Body mass index (BMI) ≥19 to ≤35 kg/m2 * No medical condition or relevant drug therapy that is known to affect the liver, adipose tissue, or cardiac metabolism. * Weight stable for the previous 3 months Exclusion Criteria: * Aged \<18 or \>65 years * BMI \<19 or \>35 kg/m2 * A blood haemoglobin \<135 mg/dL for men and \<120 mg/dL for women * Donated (or lost) ≥250 mL of blood in the previous two months * On a weight loss diet or decreased their body weight by \>5% in the previous 3 months * Currently adhering to or have consumed in the previous 3 months a diet with a notably altered macro-nutrient content (e.g. high-fat - low-carbohydrate diet) * Have increased their body weight by \>5% in the previous 3 months * Any metabolic condition or relevant drug therapy * Current smoker * History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women) * History of albumin allergy. * Pregnant or nursing mothers * History of severe claustrophobia
Where it's running
-
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford
Oxford, United Kingdom Recruiting -
Oxford Centre for Diabetes, Endocrinology and Metabolism
Oxford, United Kingdom Recruiting
Study contacts
- Principal investigator: Leane Hodson — University of Oxford
- Study coordinator: David J Dearlove
- Email: david.dearlove@ocdem.ox.ac.uk
- Phone: 07739460623
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Orforglipron for Type 2 Diabetes in Ramadan Fasters
This study tests whether orforglipron helps people with type 2 diabetes who fast during Ramadan, to see if it improves blood sugar control safely.
-
Long-term weight loss using a galactooligosaccharide (GOS) chewing gum
This study will see if a chewing gum containing galactooligosaccharides (GOS) helps adults with overweight (BMI >25) lower their weight and change their oral and gut microbiomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.